Xavier Sole

Xavier Sole

UNVERIFIED PROFILE

Are you Xavier Sole?   Register this Author

Register author
Xavier Sole

Xavier Sole

Publications by authors named "Xavier Sole"

Are you Xavier Sole?   Register this Author

31Publications

857Reads

35Profile Views

Clathrin switches transforming growth factor-β role to pro-tumorigenic in liver cancer.

J Hepatol 2019 Sep 25. Epub 2019 Sep 25.

Oncology Program, CIBEREHD, National Biomedical Research Institute on Liver and Gastrointestinal Diseases, Instituto de Salud Carlos III, 28029 Madrid, Spain; TGF-β and Cancer Group, Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), Gran Via de L'Hospitalet, 199, 08908 Barcelona, Spain; Faculty of Medicine and Health Sciences, University of Barcelona, L'Hospitalet, 08907 Barcelona, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2019.09.012DOI Listing
September 2019

Colon-specific eQTL analysis to inform on functional SNPs.

Br J Cancer 2018 10 4;119(8):971-977. Epub 2018 Oct 4.

Unit of Biomarkers and Susceptibility, Cancer Prevention and Control Program, Catalan Institute of Oncology (ICO), Barcelona, 08908, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41416-018-0018-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6203735PMC
October 2018

Integrin β1 activation induces an anti-melanoma host response.

PLoS One 2017 27;12(4):e0175300. Epub 2017 Apr 27.

Cancer Center, Massachusetts General Hospital, Boston, MA, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0175300PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5407755PMC
September 2017

AKT1 quiescent cancer cells persist after neoadjuvant chemotherapy in triple negative breast cancer.

Breast Cancer Res 2017 Aug 1;19(1):88. Epub 2017 Aug 1.

Massachusetts General Hospital Cancer Center, Richard B. Simches Research Building, 185 Cambridge Street, Boston, MA, 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13058-017-0877-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5540189PMC
August 2017

Comprehensive analysis of copy number aberrations in microsatellite stable colon cancer in view of stromal component.

Br J Cancer 2017 Jul 6;117(3):421-431. Epub 2017 Jul 6.

Unit of Biomarkers and Susceptibility, Cancer Prevention and Control Program, Catalan Institute of Oncology (ICO), CIBERESP, Gran Via 199, Hospitalet Llobregat, 08908 Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bjc.2017.208DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537504PMC
July 2017

JARID1B Enables Transit between Distinct States of the Stem-like Cell Population in Oral Cancers.

Cancer Res 2016 09 3;76(18):5538-49. Epub 2016 Aug 3.

Department of Otorhinolaryngology, University of Pennsylvania, Philadelphia, Pennsylvania. The Wistar Institute, Philadelphia, Pennsylvania. VA Medical Center, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-15-3377DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5026599PMC
September 2016

AKT Inhibition Promotes Nonautonomous Cancer Cell Survival.

Mol Cancer Ther 2016 Jan 4;15(1):142-53. Epub 2015 Dec 4.

Massachusetts General Hospital Cancer Center, Boston, Massachusetts. Harvard Medical School, Boston, Massachusetts. Broad Institute of Harvard & MIT, Cambridge, Massachusetts. Harvard Stem Cell Institute, Cambridge, Massachusetts. Harvard-Ludwig Center for Cancer Research, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-15-0414DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4707053PMC
January 2016

Discovery and validation of new potential biomarkers for early detection of colon cancer.

PLoS One 2014 12;9(9):e106748. Epub 2014 Sep 12.

Unit of Biomarkers and Susceptibility, Cancer Prevention and Control Program, Catalan Institute of Oncology (ICO) and CIBERESP, Hospitalet de Llobregat, Barcelona, Spain; Colorectal Cancer Group, Bellvitge Biomedical Research Institute (IDIBELL), Hospitalet de Llobregat, Barcelona, Spain; Department of Clinical Sciences, Faculty of Medicine, University of Barcelona (UB), Barcelona, Spain.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0106748PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4162553PMC
May 2015

A mechanism for asymmetric cell division resulting in proliferative asynchronicity.

Mol Cancer Res 2015 Feb 12;13(2):223-30. Epub 2015 Jan 12.

Massachusetts General Hospital Cancer Center, Boston, Massachusetts. Harvard Medical School, Boston, Massachusetts. Broad Institute of Harvard and MIT, Cambridge, Massachusetts. Harvard Stem Cell Institute, Cambridge, Massachusetts. Harvard-Ludwig Center for Cancer Research, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1541-7786.MCR-14-0474DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4336804PMC
February 2015

Identification of candidate susceptibility genes for colorectal cancer through eQTL analysis.

Carcinogenesis 2014 Sep 23;35(9):2039-46. Epub 2014 Apr 23.

Cancer Prevention and Control Program, Catalan Institute of Oncology, and Consortium for Biomedical Research on Epidemiology and Public Health (CIBERESP), Barcelona E08907, Spain, Colorectal Cancer Group, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona E08907, Spain, Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Barcelona E08907, Spain,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/carcin/bgu092DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4146415PMC
September 2014

Large differences in global transcriptional regulatory programs of normal and tumor colon cells.

BMC Cancer 2014 Sep 24;14:708. Epub 2014 Sep 24.

Unit of Biomarkers and Susceptibility, Cancer Prevention and Control Program, Catalan Institute of Oncology (ICO), Av Gran Via 199-203, E-08907 L'Hospitalet de Llobregat, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-14-708DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182786PMC
September 2014

Aberrant gene expression in mucosa adjacent to tumor reveals a molecular crosstalk in colon cancer.

Mol Cancer 2014 Mar 5;13:46. Epub 2014 Mar 5.

Unit of Biomarkers and Susceptibility, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL) and CIBERESP, L'Hospitalet de Llobregat, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1476-4598-13-46DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023701PMC
March 2014

Clinical value of prognosis gene expression signatures in colorectal cancer: a systematic review.

PLoS One 2012 7;7(11):e48877. Epub 2012 Nov 7.

Unit of Biomarkers and Susceptibility (UBS), Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), and CIBERESP, L'Hospitalet de Llobregat, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0048877PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492249PMC
May 2013

Tools for protein-protein interaction network analysis in cancer research.

Clin Transl Oncol 2012 Jan;14(1):3-14

Catalan Institute of Oncology, Bellvitge Institute for Biomedical Research, Biomedical Research Centre Network for Epidemiology and Public Health, L'Hospitalet de Llobregat, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12094-012-0755-9DOI Listing
January 2012

Pre-clinical validation of early molecular markers of sensitivity to aromatase inhibitors in a mouse model of post-menopausal hormone-sensitive breast cancer.

Breast Cancer Res Treat 2008 Jun 19;109(3):463-70. Epub 2007 Jul 19.

Translational Research Laboratory, Institut Català d'Oncologia, IDIBELL, Gran via s/n, km 2.7, L'Hospitalet de Llobregat, Barcelona, 08907, Spain.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s10549-007-9676
Web Search
http://link.springer.com/10.1007/s10549-007-9676-7
Publisher Site
http://dx.doi.org/10.1007/s10549-007-9676-7DOI Listing
June 2008

CLEAR-test: combining inference for differential expression and variability in microarray data analysis.

J Biomed Inform 2008 Feb 17;41(1):33-45. Epub 2007 May 17.

Bioinformatics and Biostatistics Unit, and Translational Research Laboratory, Catalan Institute of Oncology, IDIBELL, L'Hospitalet, 08907 Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jbi.2007.05.005DOI Listing
February 2008

Genomic and transcriptomic prognostic factors in R0 Dukes B and C colorectal cancer patients.

Int J Oncol 2007 May;30(5):1099-107

Institut d'Investigació Biomèdica de Bellvitge, L'Hospitalet, Barcelona, Catalonia, Spain.

View Article

Download full-text PDF

Source
May 2007

SNPassoc: an R package to perform whole genome association studies.

Bioinformatics 2007 Mar 31;23(5):644-5. Epub 2007 Jan 31.

Genes and Disease Program, Centre for Genomic Regulation, IDIBELL, Catalan Institute of Oncology, Barcelona, Spain.

View Article

Download full-text PDF

Source
https://academic.oup.com/bioinformatics/article-lookup/doi/1
Publisher Site
http://dx.doi.org/10.1093/bioinformatics/btm025DOI Listing
March 2007

Integrative analysis of a cancer somatic mutome.

Mol Cancer 2007 Feb 5;6:13. Epub 2007 Feb 5.

Bioinformatics and Biostatistics Unit, and Translational Research Laboratory, Catalan Institute of Oncology, IDIBELL, L'Hospitalet, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1476-4598-6-13DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1797053PMC
February 2007

Differential DNA hypermethylation and hypomethylation signatures in colorectal cancer.

Hum Mol Genet 2005 Jan 1;14(2):319-26. Epub 2004 Dec 1.

IDIBELL-Institut de Recerca Oncològica, L'Hospitalet, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/hmg/ddi028DOI Listing
January 2005

Validation of RNA arbitrarily primed PCR probes hybridized to glass cDNA microarrays: application to the analysis of limited samples.

Clin Chem 2005 Jan;51(1):93-101

Institut d'Investigació Biomèdica de Bellvitge-Institut Català d'Oncologia, Translational Research Laboratory, Unit of Biostatistics and Bioinformatics, Cancer Epidemiology Department, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://www.clinchem.org/cgi/doi/10.1373/clinchem.2004.036236
Publisher Site
http://dx.doi.org/10.1373/clinchem.2004.036236DOI Listing
January 2005

[Use of DNA chips (microarrays) in medicine: technical foundations and basic procedures for statistical analysis of results].

Med Clin (Barc) 2004 ;122 Suppl 1:73-9

Unidad de Bioestadística y Bioinformática, Servicio de Epidemiología y Registro del Cáncer, Instituto Catalán de Oncología, Hospital Duran i Reynals, L'Hospitalet de Llobregat, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1157/13057538DOI Listing
July 2004